Fingerprint
Dive into the research topics of 'Nilotinib: A novel Bcr-Abl tyrosine kinase inhibitor for the treatment of leukemias'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Nilotinib: A novel Bcr-Abl tyrosine kinase inhibitor for the treatment of leukemias
Elias Jabbour, Samih El Ahdab, Jorge Cortes, Hagop Kantarjian
Research output: Contribution to journal › Article › peer-review
13
Scopus
citations